BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17134062)

  • 1. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.
    Kouris NT; Kontogianni DD; Papoulia EP; Goranitou GS; Zaharos ID; Grassos HA; Kalkandi EM; Sifaki MD; Babalis DK
    Hellenic J Cardiol; 2006; 47(5):269-74. PubMed ID: 17134062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters.
    Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK
    Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
    D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
    J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
    Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
    Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
    Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
    Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients.
    Vizzardi E; D'Aloia A; Pezzali N; Bugatti S; Curnis A; Dei Cas L
    J Card Fail; 2012 Jan; 18(1):68-73. PubMed ID: 22196844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
    Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
    Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic value of elevated CA125 levels in patients with coronary heart disease.
    Rong X; Yunke Z; Guoping L; Zhenyue C
    Herz; 2015 Jun; 40(4):690-4. PubMed ID: 24831034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
    Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
    Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
    Demir M; Kanadasi M; Akpinar O; Dönmez Y; Avkarogullari M; Alhan C; Inal T; San M; Usal A; Demirtas M
    Angiology; 2007; 58(5):603-9. PubMed ID: 18024945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
    Husser O; Núñez J; Núñez E; Holzamer A; Camboni D; Luchner A; Sanchis J; Bodi V; Riegger GA; Schmid C; Hilker M; Hengstenberg C
    JACC Cardiovasc Interv; 2013 May; 6(5):487-96. PubMed ID: 23702013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
    Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of BNP and tumour marker CA125 in patients with heart failure.
    Chen YX; Wang XQ; Fang CF; Wang JF; Tang LJ
    Acta Cardiol; 2008 Aug; 63(4):501-6. PubMed ID: 18795589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum carbohydrate antigen 125 levels in nonischemic dilated cardiomyopathy: a useful biomarker for prognosis and functional mitral regurgitation.
    Karaca O; Guler GB; Guler E; Gunes HM; Alizade E; Agus HZ; Gol G; Kahveci G; Esen O; Esen AM; Turkmen M
    Congest Heart Fail; 2012; 18(3):144-50. PubMed ID: 22587744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.
    Jankowska EA; Pietruk-Kowalczyk J; Zymliński R; Witkowski T; Ponikowska B; Sebzda T; Rzeczuch K; Borodulin-Nadzieja L; Hańczycowa H; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Aug; 59(8):115-27; commentary 126-7. PubMed ID: 14560326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure.
    Pan JP; Liu TY; Chiang SC; Lin YK; Chou CY; Chan WL; Lai ST
    J Chin Med Assoc; 2004 May; 67(5):222-8. PubMed ID: 15357108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
    Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
    JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
    Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
    Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
    PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
    Núñez J; Núñez E; Consuegra L; Sanchis J; Bodí V; Martínez-Brotons A; Bertomeu-González V; Robles R; Bosch MJ; Fácila L; Darmofal H; Llàcer A
    Heart; 2007 Jun; 93(6):716-21. PubMed ID: 17164487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.